Novel Therapeutic Approach for Human T-cell Malignancies

This study is testing a new treatment approach for T-cell leukemia and lymphoma — cancers that affect a specific type of immune cell called T-cells. These cancers are rare and can be difficult to treat, so researchers are exploring novel therapies. **You may be eligible if...** - You have been diagnosed with T-cell leukemia or lymphoma (either before or after thymic origin) - You are 18 or older - You are willing to provide written informed consent **You may NOT be eligible if...** - You have a serious medical condition or uncontrolled active infection that would prevent you from receiving standard treatment protocols Talk to your doctor to see if this trial is right for you.